According to IDEAYA Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 127.698. At the end of 2023 the company had a P/S ratio of 98.1.
Year | P/S ratio | Change |
---|---|---|
2023 | 98.1 | 471.39% |
2022 | 17.2 | -47.35% |
2021 | 32.6 | 54.04% |
2020 | 21.2 | |
2019 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |